Keyphrases
Inflammation
100%
NLRP3 Inflammasome
100%
Gasdermin D (GSDMD)
100%
Gasdermin
100%
Interleukin-1β
41%
Macrophages
25%
Interleukin-18 (IL-18)
25%
NOD-like Receptor Protein 3 (NLRP3)
25%
Gasdermin E (GSDME)
25%
Pyroptosis
16%
Caspase-8
16%
Signaling Cascades
8%
Disulfiram
8%
Gain-of-function mutation
8%
Inflammatory Pathways
8%
Protein Complex
8%
Plasma Membrane
8%
Inflammasome
8%
FDA-approved Drugs
8%
Genetic Data
8%
Bioactive
8%
Constitutive Activation
8%
Tissue Damage
8%
Active Metabolite
8%
Inflammasome Activation
8%
Membrane Pore
8%
Inflammatory Cell Death
8%
Danger Signals
8%
Severe Inflammation
8%
Amino-terminal Fragment
8%
In Vitro Maturation
8%
CuET
8%
NLRP3 Activation
8%
Spontaneous Inflammation
8%
Inflammasome Assembly
8%
Immunology and Microbiology
NLRP3 Inflammasome
100%
Gasdermin D
100%
Interleukin-1
62%
Macrophage
37%
Interleukin 18
37%
Inflammasome
37%
Caspase
25%
Pyroptosis
25%
Secretion (Process)
12%
Cytokine
12%
Tumor Necrosis Factor
12%
Cell Death
12%
Infectious Agent
12%
Amino Terminal Sequence
12%
Maturation
12%
Cell Membrane
12%
Experimental Model
12%
Inflammatory Cell
12%
Metabolite
12%
NOD-like Receptor
12%
Pyrin Domain
12%
Gain of Function Mutation
12%
Protein Complex
12%